In humans, higher blood levels of glial fibrillary acidic protein (GFAP), a marker of astrocyte reactivity, have been reported in AD patients compared to controls (Abdelhak et al. (2022) [248]). The gene discussed is GFAP; the disease is Alzheimer disease.